AI Article Synopsis

  • * New techniques like whole-transcriptome and single-cell sequencing identified a specific immune cell population, MG-Act, in certain pediatric gliomas, which express the TIM3 protein linked to inflammation and immune response.
  • * Treating a mouse model of low-grade gliomas with anti-TIM3 significantly increased survival compared to standard treatments, suggesting that anti-TIM3 could be a promising option for clinical trials targeting pediatric MAPK-driven gliomas.

Article Abstract

Despite being the leading cause of cancer-related childhood mortality, pediatric gliomas have been relatively understudied, and the repurposing of immunotherapies has not been successful. Whole-transcriptome sequencing, single-cell sequencing, and sequential multiplex immunofluorescence were used to identify an immunotherapeutic strategy that could be applied to multiple preclinical glioma models. MAPK-driven pediatric gliomas have a higher IFN signature relative to other molecular subgroups. Single-cell sequencing identified an activated and cytotoxic microglia (MG) population designated MG-Act in BRAF-fused, MAPK-activated pilocytic astrocytoma (PA), but not in high-grade gliomas or normal brain. T cell immunoglobulin and mucin domain 3 (TIM3) was expressed on MG-Act and on the myeloid cells lining the tumor vasculature but not normal brain vasculature. TIM3 expression became upregulated on immune cells in the PA microenvironment, and anti-TIM3 reprogrammed ex vivo immune cells from human PAs to a proinflammatory cytotoxic phenotype. In a genetically engineered murine model of MAPK-driven, low-grade gliomas, anti-TIM3 treatment increased median survival over IgG- and anti-PD-1-treated mice. Single-cell RNA-Seq data during the therapeutic window of anti-TIM3 revealed enrichment of the MG-Act population. The therapeutic activity of anti-TIM3 was abrogated in mice on the CX3CR1 MG-KO background. These data support the use of anti-TIM3 in clinical trials of pediatric low-grade, MAPK-driven gliomas.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11444160PMC
http://dx.doi.org/10.1172/JCI177413DOI Listing

Publication Analysis

Top Keywords

pilocytic astrocytoma
8
pediatric gliomas
8
single-cell sequencing
8
normal brain
8
immune cells
8
gliomas
5
anti-tim3
5
pediatric
4
pediatric glioma
4
glioma immune
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!